logo

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 12377112 B1

PDFFull Text
Date of Patent:
Aug. 05, 2025

Filed:

Apr. 17, 2020

Methods of treating neurocognitive disorders, chronic pain and reducing inflammation

Applicant:

Compass Pathfinder Limited, Altrincham, GB;

Inventors:

Derek John Londesbrough, Hartlepool, GB;

Christopher Brown, Gateshead, GB;

Julian Scott Northen, South Shields, GB;

Gillian Moore, Sedgefield, GB;

Hemant Kashinath Patil, Surrey, GB;

David E. Nichols, Chapel Hill, NC (US);

Hans Ake Eriksson, Altrincham, GB;

George Goldsmith, Altrincham, GB;

Ekaterina Malievskaia, Altrincham, GB;

Manon Cecile Elisabeth Veraart, Altrincham, GB;

Tobias Patrick Whelan, Altrincham, GB;

Lars Christian Wilde, Altrincham, GB;

Assignee:

Compass Pathfinder Limited, Altrincham, GB;

Attorney:

COOLEY LLP

Primary Examiner:

Joseph K Mckane

Assistant Examiner:

Anna Grace Kuckla

Int. Cl.
CPC ...
A61K 31/675 (2006.01); A61K 9/00 (2006.01); A61K 9/20 (2006.01); A61K 9/48 (2006.01); A61K 31/661 (2006.01); A61P 25/00 (2006.01); A61P 25/04 (2006.01); A61P 25/08 (2006.01); A61P 25/16 (2006.01); A61P 25/20 (2006.01); A61P 25/22 (2006.01); A61P 25/24 (2006.01); A61P 25/28 (2006.01); C07F 9/572 (2006.01);
U.S. Cl.
CPC ...
A61K 31/675 (2013.01); A61K 9/0053 (2013.01); A61K 9/20 (2013.01); A61K 9/48 (2013.01); A61K 31/661 (2013.01); A61P 25/00 (2018.01); A61P 25/04 (2018.01); A61P 25/08 (2018.01); A61P 25/16 (2018.01); A61P 25/20 (2018.01); A61P 25/22 (2018.01); A61P 25/24 (2018.01); A61P 25/28 (2018.01); C07F 9/5728 (2013.01); C07B 2200/13 (2013.01);
Abstract

The disclosure provides methods for treating a subject in need thereof comprising administering to the subject a therapeutically-effective dose of psilocybin. The methods described herein may be used to treat a variety of diseases, disorders, and conditions. For example, the methods may be used to treat neurocognitive disorders (e.g., Alzheimer's disease, Parkinson's disease), ADHD, Epilepsy, Autism, Sleep-wake disorders, Chronic pain, Inflammatory Disorders, IBD, Stroke, ALS, and/or Multiple Sclerosis.

Find Patent Forward Citations

Loading…